SymBio Pharmaceuticals Statistics
Total Valuation
SYMQY has a market cap or net worth of 56.27 million. The enterprise value is 36.69 million.
| Market Cap | 56.27M |
| Enterprise Value | 36.69M |
Important Dates
The next estimated earnings date is Thursday, July 31, 2025.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +13.09% |
| Shares Change (QoQ) | +3.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 44.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.98 |
| PB Ratio | 2.48 |
| P/TBV Ratio | 2.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.26 |
| EV / Sales | 2.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.20, with a Debt / Equity ratio of 0.21.
| Current Ratio | 8.20 |
| Quick Ratio | 6.78 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -74.11 |
Financial Efficiency
Return on equity (ROE) is -84.21% and return on invested capital (ROIC) is -47.76%.
| Return on Equity (ROE) | -84.21% |
| Return on Assets (ROA) | -42.79% |
| Return on Invested Capital (ROIC) | -47.76% |
| Return on Capital Employed (ROCE) | -103.33% |
| Revenue Per Employee | 131,027 |
| Profits Per Employee | -270,675 |
| Employee Count | 108 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 2.40 |
Taxes
In the past 12 months, SYMQY has paid 249,306 in taxes.
| Income Tax | 249,306 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.29% in the last 52 weeks. The beta is 0.28, so SYMQY's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -1.29% |
| 50-Day Moving Average | 0.94 |
| 200-Day Moving Average | 1.15 |
| Relative Strength Index (RSI) | 94.91 |
| Average Volume (20 Days) | 23 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SYMQY had revenue of 14.15 million and -29.23 million in losses. Loss per share was -0.63.
| Revenue | 14.15M |
| Gross Profit | 10.71M |
| Operating Income | -28.31M |
| Pretax Income | -28.98M |
| Net Income | -29.23M |
| EBITDA | n/a |
| EBIT | -28.31M |
| Loss Per Share | -0.63 |
Balance Sheet
The company has 24.14 million in cash and 4.67 million in debt, giving a net cash position of 19.46 million.
| Cash & Cash Equivalents | 24.14M |
| Total Debt | 4.67M |
| Net Cash | 19.46M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 22.69M |
| Book Value Per Share | 0.47 |
| Working Capital | 27.14M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 75.72%, with operating and profit margins of -200.06% and -206.58%.
| Gross Margin | 75.72% |
| Operating Margin | -200.06% |
| Pretax Margin | -204.82% |
| Profit Margin | -206.58% |
| EBITDA Margin | n/a |
| EBIT Margin | -200.06% |
| FCF Margin | n/a |
Dividends & Yields
SYMQY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.09% |
| Shareholder Yield | n/a |
| Earnings Yield | -51.95% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SYMQY has an Altman Z-Score of -7.12. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.12 |
| Piotroski F-Score | n/a |